B of A Securities maintains Buy rating on Colgate-Palmolive, lowers PT to $88.

B of A Securities maintains Buy rating on Colgate-Palmolive, lowers PT to $88.

B of A Securities has maintained its 'Buy' rating on Colgate-Palmolive (CL) but has lowered its price target to $88, according to a recent update Colgate-Palmolive (CL) Rating Maintained, Price Target Lowered to $88 | CL Stock News^[1]. This adjustment represents a 10.20% decrease from the previous target of $98.00. The latest rating was provided by analyst Bryan Spillane, reflecting a cautious sentiment towards the stock while still expressing confidence in its long-term prospects.

This move comes amidst a trend of reduced price targets from multiple analysts. Over the past few months, several analysts have adjusted their price targets downward, indicating a more conservative outlook. For instance, Piper Sandler lowered its target to $84.00 in October 2025, while Goldman Sachs reduced its target to $91.00 in the same month. These adjustments suggest a cautious approach among analysts, despite the majority maintaining 'Buy' ratings.

Colgate-Palmolive, founded in 1806, is a leading player in the household and personal care industry. Its diverse product portfolio includes oral care, shampoos, shower gels, deodorants, and home care products, sold in over 200 countries. The company's international sales account for about 70% of its total business, with a significant portion coming from emerging regions. Additionally, it owns Hill's, a specialty pet food maker, which contributes around one-fifth of its sales.

Analysts' consensus remains largely positive. Based on 20 analysts' one-year price targets, the average target price is $92.66, with a high estimate of $106.00 and a low estimate of $79.00. The average target implies an upside of 18.35% from the current price of $78.29. The consensus brokerage recommendation is "Outperform," with 22 firms giving an average rating of 2.5 out of 5.

GuruFocus estimates the GF Value for Colgate-Palmolive to be $94.79 in one year, suggesting an upside of 21.08% from the current price. The GF Value is calculated based on historical multiples and future performance estimates.

Overall, while the price target adjustment reflects a cautious stance, the majority of analysts remain bullish on Colgate-Palmolive's long-term prospects.